EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens

Sana Khan Khilji, Charlotte Op 't Hoog, David Warschkau, Jost Lühle, Felix Goerdeler, Anika Freitag, Peter H Seeberger, Oren Moscovitz

Theranostics · 2023 · 13 (9) · 3041-3063

DOI: 10.7150/thno.80901 ↗

At a glance

Übersichtsarbeit in Theranostics, 2023. Written by Sana Khan Khilji and 7 co-authors. Institution: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany. Major MEDLINE topics: Immunoglobulin Fragments, Neoplasms. Cited 19 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Attached to proteins, lipids, or forming long, complex chains, glycans represent the most versatile post-translational modification in nature and surround all human cells. Unique glycan structures are monitored by the immune system and differentiate self from non-self and healthy from malignant cells. Aberrant glycosylations, termed tumour-associated carbohydrate antigens (TACAs), are a hallmark of cancer and are correlated with all aspects of cancer biology. Therefore, TACAs represent attractive targets for monoclonal antibodies for cancer diagnosis and therapy. However, due to the thick and dense glycocalyx as well as the tumour micro-environment, conventional antibodies often suffer from restricted access and limited effectiveness in vivo. To overcome this issue, many small antibody fragments have come forth, showing similar affinity with better efficiency than their full-length counterparts. Here we review small antibody fragments against specific glycans on tumour cells and highlight their advantages over conventional antibodies.

Subjects

MeSH terms (MEDLINE)

Immunoglobulin FragmentsNeoplasmsHumansAntigens, Tumor-Associated, CarbohydrateAntibodies, MonoclonalPolysaccharidesTumor Microenvironment

Author keywords

CAR T-cellScFvTACAsTumouraberrant glycosylationcancercancer antigenscancer glycanscarbohydrateschimeric antigen receptorsfragmentsglycansimmunologynanobodysingle domain antibodies

Substances

Immunoglobulin FragmentsAntigens, Tumor-Associated, CarbohydrateAntibodies, MonoclonalPolysaccharides

Authors and institutions

  • Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany.
  • Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.
  • Graduate School of Life Sciences, Utrecht University, 3584 CH Utrecht, Netherlands.
  • Institute of Chemistry, University of Potsdam, 14476 Potsdam, Germany.

Cite

APA

Khilji, S. K., Op 't Hoog, C., Warschkau, D., Lühle, J., Goerdeler, F., Freitag, A., Seeberger, P. H., & Moscovitz, O. (2023). Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens. Theranostics, 13(9), 3041-3063. https://doi.org/10.7150/thno.80901

Vancouver

Khilji SK, Op 't Hoog C, Warschkau D, Lühle J, Goerdeler F, Freitag A, et al. Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens. Theranostics. 2023;13(9):3041-3063. doi:10.7150/thno.80901

BibTeX
@article{Khilji2023,
  author = {Khilji, Sana Khan and Op 't Hoog, Charlotte and Warschkau, David and Lühle, Jost and Goerdeler, Felix and Freitag, Anika and Seeberger, Peter H and Moscovitz, Oren},
  title = {Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens},
  journal = {Theranostics},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {3041--3063},
  doi = {10.7150/thno.80901}
}
Start for free →